financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Hold Opinion On Shares Of Enbridge Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Hold Opinion On Shares Of Enbridge Inc.
Nov 21, 2025 12:33 PM

03:05 PM EST, 11/21/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Our 12-month target price remains USD50, reflecting a combination of our relative valuation and DCF model analyses. On a relative basis, we apply an 11.8x multiple of enterprise value to projected 2026 EBITDA, in line with ENB's historical forward average. That approach yields a value of CAD64 per share. Meanwhile, our DCF model, using free cash flow growth of 5.5% per year for 10 years, 2.0% thereafter, discounted at a WACC of 6.1%, yields a value of CAD75 per share. We cut our 2025 EPS estimate by CAD0.11 to CAD2.92, but lift 2026's by CAD0.09 to CAD3.19. ENB is facing a mixed bag of headwinds and tailwinds, with crude oil fundamentals in the former camp, and natural gas in the latter camp. We also note ongoing regulatory risk surrounding ENB's Line 5 pipeline in Michigan and Wisconsin. Much of ENB's project backlog is gas-related, which we think has solid long-term prospects, but its valuation appears fairly full at the moment. Shares yield 5.5%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Retains Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Research Alert: CFRA Retains Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Jul 8, 2025
01:00 PM EDT, 07/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price to $367 from $343 based on our net present value (NPV) analysis. We lift our 2025 EPS estimate to $1.15 from $0.69, as we...
Research Alert: CFRA Maintains Buy Opinion On Shares Of O'reilly Automotive Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of O'reilly Automotive Inc.
Jul 8, 2025
12:30 PM EDT, 07/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We are updating our price target for the company's recently-completed 15-for-1 stock split. As a result, our price target goes to $100 from $1,500, based on a 2026 P/E of...
Research Alert: CFRA Initiates Coverage On Shares Of Robinhood Markets Inc. With A Buy Opinion
Research Alert: CFRA Initiates Coverage On Shares Of Robinhood Markets Inc. With A Buy Opinion
Jul 8, 2025
07:55 AM EDT, 07/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We initiate coverage on HOOD with a Buy rating and target of $118, 62.1x our 2026 EPS estimate, reflecting a premium to the company's three-year forward P/E average of 46.5x....
Research Alert: CFRA Keeps Buy Opinion On Shares Of Amphenol Corporation
Research Alert: CFRA Keeps Buy Opinion On Shares Of Amphenol Corporation
Jul 8, 2025
11:30 AM EDT, 07/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price to $110 from $85, shifting to a P/E of 37x our 2026 EPS view, above APH's three-year average (~28x) on sizeable AI tailwinds. We also...
Copyright 2023-2026 - www.financetom.com All Rights Reserved